Compared to saline-treated AOM mice, etanercept-pretreated mice displayed significantly lower levels of plasma TNF-α (2.5-fold; p<0.05), IL-6 (4.1-fold; p<0.001) and CD40L (3.7-fold; p<0.001). The gene discussed is CD40LG; the disease is infectious otitis media.